0001406718-20-000025.txt : 20200518 0001406718-20-000025.hdr.sgml : 20200518 20200518103333 ACCESSION NUMBER: 0001406718-20-000025 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200518 DATE AS OF CHANGE: 20200518 EFFECTIVENESS DATE: 20200518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Corriente Advisors, LLC CENTRAL INDEX KEY: 0001406718 IRS NUMBER: 752939516 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12875 FILM NUMBER: 20888348 BUSINESS ADDRESS: STREET 1: 1401 FOCH ST STREET 2: SUITE 100 CITY: FORT WORTH STATE: TX ZIP: 76107 BUSINESS PHONE: 8178700400 MAIL ADDRESS: STREET 1: 1401 FOCH ST STREET 2: SUITE 100 CITY: FORT WORTH STATE: TX ZIP: 76107 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001406718 XXXXXXXX 03-31-2020 03-31-2020 Corriente Advisors, LLC
1401 FOCH ST SUITE 100 FORT WORTH TX 76107
13F HOLDINGS REPORT 028-12875 N
Matthew H. Gilman CFO / CCO 817 870-0404 /s/Matthew Gilman Fort Worth TX 05-15-2020 0 11 92638 false
INFORMATION TABLE 2 form13fInfoTable.xml DESCRIPTION FOR INFORMATION TABLE APTOSE BIOSCIENCES INCCOM NEW03835T200173332918000SHSOLE1291800000BELLUS HEALTH INC NEWCOM NEW07987C2041484148666SHSOLE114866600CUE BIOPHARMA INCCOM22978P10611636820000SHSOLE182000000EPIZYME INCCOM29428V1043567230000SHSOLE123000000GRAYSCALE BITCOIN ORDCOM3896371094201590000SHSOLE159000000MAXAR TECHNOLOGIES INCCOM57778K105180401689100SHSOLE1168910000PIERIS PHARMACEUTICALS INCCOM72079510340631781921SHSOLE1178192100REATA PHARMACEUTICALS INCCL A75615P10327425190000SHSOLE119000000SCHRODINGER ORDCOM80810D103258760000SHSOLE16000000SUNESIS PHARMACEUTICALS INCCOM86732870012543021692SHSOLE1302169200TESLA INCCOM88160R10110482000SHSOLE1200000